VA Video Connect in HIV Care

August 3, 2026 updated by: VA Office of Research and Development

VA Video Connect to Improve Access to Multi-disciplinary Specialty Care

The purpose of this research study is to see how effective the addition of video to home telehealth services is in helping patients with HIV to remain in care, which is vital to management of their illness. The investigators also want to understand how to best put the video to home services into practice.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

306

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030-4211
        • Michael E. DeBakey VA Medical Center, Houston, TX

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient in the Infectious Diseases clinic at Michael E. DeBakey VA Medical Center (MEDVAMC), Houston, TX, with HIV infection
  • At least 18 years of age
  • Able to speak English
  • Able to consent to the use of VVC

Exclusion Criteria:

  • Unable to use or consent to use VVC, due to either significant physical or mental disability
  • Incarcerated (though MEDVAMC does not generally provide care for prisoners)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VVC
Option to receive VA Video Connect (VVC) delivery of HIV care.
Other: VVC
Telehealth treatment is delivered via VA-approved technology to a patient's computer or mobile device.
Other Names:
  • VA Video Connect
No Intervention: Usual Care
All HIV care available at MEDVAMC will be delivered as usual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constancy Retention in Care Measure
Time Frame: From enrollment to the end of follow-up at 12 months
Completion of at least 1 visit with a primary care or Infectious Disease provider in each 6 months of the year at least 60 days apart.
From enrollment to the end of follow-up at 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence Retention in Care Measure
Time Frame: 12 months
Percentage of scheduled HIV clinic appointments attended over 12 months
12 months
Completed Visits for Adherence Counseling
Time Frame: 12 months
Number of completed visits for counseling, mental health, and social services during the year.
12 months
HIV Suppression
Time Frame: 12 months
Number of Veterans with HIV on ART whose most recent viral load during the 12-month period was <200c/mL
12 months
Percent ART Medication Dispensed (as a Proxy for Medication Adherence)
Time Frame: 12 months
The percentage of ART medication dispensed was calculated by dividing the total number of ART medication pills dispensed during each 365-day observation period (i.e., baseline and 12-month follow-up) by 365 and then multiplying by 100, yielding a percentage (0-100%). This pharmacy dispensing measure serves as a proxy for medication adherence, with higher percentages indicating greater medication availability.
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
CD4 Cell Count Greater Than or Equal to 200
Time Frame: 12 months
Last recorded value in medical record during 12 month period
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

VA Office of Research and Development

Investigators

  • Principal Investigator: Jan Alexandra Lindsay, PhD, Michael E. DeBakey VA Medical Center, Houston, TX

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Actual)

October 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

July 24, 2019

First Submitted That Met QC Criteria

August 9, 2019

First Posted (Actual)

August 13, 2019

Study Record Updates

Last Update Posted (Actual)

August 26, 2026

Last Update Submitted That Met QC Criteria

August 3, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IIR 18-077
  • I01HX002645 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe